Great Britain’s riders got their UCI Track World Championships off to a strong start with a pair of silver medals in the men’s and women’s team sprints. Individual sprint world champion Emma Finucane ...

Eli Lilly’s Verzenio (abemaciclib) boosted overall survival (OS) in the adjuvant breast cancer setting during a late-stage trial. In the Phase III monarchE study, (NCT02763566), Verzenio plus ...

Eli Lilly’s CDK 4/6 inhibitor, Verzenio, has been shown to prolong OS when used alongside endocrine therapy as an adjuvant treatment for HR+, HER2- early, high-risk breast cancer in a Phase III trial.

INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), a prominent player in the pharmaceuticals industry with a market capitalization of $735 billion and impressive revenue growth of 37% over the last ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer. Seven-year results from the ...

Death daddy Pluto is going direct in the sign of the strange -- here are the zodiac signs that will feel the shift most acutely. NY Post photo composite Pluto, our planet of profound change and ...